fluorocitrate has been researched along with Bone Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, H; Ji, FH; Li, CF; Peng, J; Peng, Y; Wang, LN; Wang, XY; Xu, QN; Yang, JP; Yao, M; Zhang, YB; Zuo, JL | 1 |
1 other study(ies) available for fluorocitrate and Bone Neoplasms
Article | Year |
---|---|
Cancer-induced bone pain sequentially activates the ERK/MAPK pathway in different cell types in the rat spinal cord.
Topics: Analgesics; Animals; Bone Neoplasms; Butadienes; Citrates; Cyclic AMP Response Element-Binding Protein; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Hyperalgesia; Injections, Spinal; MAP Kinase Signaling System; Nitriles; Organ Specificity; Pain; Phosphorylation; Radiography; Rats; Rats, Sprague-Dawley; Spinal Cord; Tibia | 2011 |